NRG 2026 Winter Meeting

Thank you for attending #NRG2026!

#NRG2026 Winter Meeting

A Focus On Science

NRG Oncology and its partners have more than 150 years experience in conducting practice-defining, multi-institutional phase II and III trials sponsored primarily by the National Cancer Institute (NCI), as well as a history of undertaking the kind of phase I trials and translational biological studies that will be imperative for future clinical cancer research.

 

logo that reads NCI Community Oncology Research Program. A program of the National Cancer Institute of the National Institutes of Health
logo that reads NCI National Clinical Trials Network. A National Cancer Institute program

Our Mission

Improve the lives of patients with cancer by conducting practice-changing multi-institutional clinical and translational research

Dr. Robert S. Mannel

Our exceptional network brings individuals together who are passionate about changing the future of cancer care through impactful clinical trials.
on large grey diamond on top of another smaller grey diamond

Membership Resources

NRG Oncology’s membership roster is comprised of over 1,000 member sites including institutions on five continents. Our investigators represent all of the oncologic medical specialties and disciplines.

Learn More

Latest News

Greg Yothers, PhD, to Retire from the University of Pittsburgh and the NRG Oncology SDMC

Dr. Greg Yothers, Senior Deputy Director and Deputy Group Statistician of the NRG Oncology Statistics and Data Management Center (SDMC), and Research Professor of Biostatistics at the Graduate School of Public Health, University of Pittsburgh, is retiring after 20 years of leadership in the cooperative group setting.

Read More
NRG Oncology PSC 2026 Winter Meeting Wrap Up

The Protocol Support Committee (PSC) would like to thank everyone who joined us for our winter meeting in San Francisco, CA. There were 104 in-person attendees and 295 virtual attendees at the PSC Nurse/CRA Continuing Education Session held on Thursday morning, January 22nd, 2026. Our Discuss With Us – Live session early Thursday afternoon (for in-person attendees only) included 83 attendees. Closing out the day on Thursday was our Protocol Spotlight session, in which there were 60 in-person attendees and 76 virtual.

Read More
We Have the Tools: Preventing Cancer Before it Begins

We have the tools to prevent HPV-derived cancers. It is supposed to be about prevention, not diagnosing the cancer.” – Dr. Joan Walker

Read More
See All Posts

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.